Chunghwa Chemical Synthesis & Biotech Co., Ltd. Appoints Wang, Hou-Jie as Director's Representative
January 17, 2020 at 07:39 am
Share
Chunghwa Chemical Synthesis & Biotech Co., Ltd. announced that Wang, Hou-Jie,foundation's representative of Wang Min-ning, and deputy general manager of Suzhou Chung-Hwa Chemical & Pharmaceutical Industrial CO., LTD as director's representative. The appointment was effective from January 01, 2020.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the manufacture and distribution of biotechnology products and chemical synthetic products. The Company's biotechnology products include pravastatin, rapamycin, tacrolimus, everolimus, mycophenolate mofetil, mycophenolic acid sodium and others. Its non-biotechnology products include methocarbamol, guaifenesin, trandolapril, fluconazole, olopatadine, dexbromopheniramine maleate and glipizide, among others. Its products are applied in the manufacture of drugs for treatment of cough, diabetes, cardiovascular diseases, high blood pressure and immune system diseases. The Company distributes its products within domestic market and to overseas markets, including the rest of Asia, the Americas and Europe.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. 
